Medicare Enrolled
Dr. Benjamin Jacobs, MD
Internal Medicine · Media, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jacobs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobs?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jacobs
Dr. Benjamin Jacobs is an internal medicine specialist in Media, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Jacobs performed 55,145 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jacobs received a total of $24,784 from 65 pharmaceutical and/or device companies across 365 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jacobs is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 0% volume in PA
$24,784 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗55,145
Medicare services
Top 0% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 18,800 | $43 | $139 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
13,080 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 7,860 | $18 | $69 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,100 | $0 | $6 |
| Iron infusion (Monoferric) | 3,300 | $16 | $73 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,037 | $8 | $35 |
| Anti-nausea injection (Aloxi/palonosetron) | 920 | $1 | $122 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
870 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
841 | $8 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
605 | $101 | $224 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
551 | $72 | $148 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
468 | $87 | $879 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
271 | $113 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
270 | $12 | $93 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
226 | $13 | $105 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
114 | $42 | $115 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
95 | $108 | $299 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $25 | $152 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
69 | $2 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
66 | $27 | $249 |
| New patient office visit, complex (60-74 min) | 61 | $180 | $432 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $150 | $301 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $55 | $304 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
45 | $63 | $205 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $56 | $334 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $29 | $141 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
36 | $1 | $9 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
30 | $24 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $146 | $412 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
27 | $48 | $281 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
26 | $21 | $111 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
26 | $1 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $126 | $343 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
18 | $11 | $73 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.0% high complexity
86.6% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,784
Total received (2018-2024)
Avg $3,541/year across 7 years
Top 3% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
365
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,830
2023
$139
2022
$1,500
2021
$238
2020
$6,006
2019
$2,968
2018
$12,104
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$229
Novartis Pharmaceuticals Corporation
$142
Alexion Pharmaceuticals, Inc.
$136
ABBVIE INC.
$120
Daiichi Sankyo Inc.
$115
Janssen Biotech, Inc.
$98
Acrotech Biopharma Inc.
$84
Incyte Corporation
$75
ARRAY BIOPHARMA INC
$75
Lilly USA, LLC
$67
E.R. Squibb & Sons, L.L.C.
$65
PFIZER INC.
$62
Merck Sharp & Dohme LLC
$62
SOBI, INC
$62
Eisai Inc.
$55
EMD Serono, Inc.
$49
Tempus AI, Inc
$44
Gilead Sciences, Inc.
$44
Mirati Therapeutics, Inc.
$44
GENZYME CORPORATION
$35
Stemline Therapeutics Inc.
$23
Celgene Corporation
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
BeiGene USA, Inc.
$21
Myriad Genetic Laboratories, Inc.
$21
SpringWorks Therapeutics, Inc.
$20
GlaxoSmithKline, LLC.
$20
Pharmacosmos Therapeutics Inc.
$17
Top 3 companies account for 27.7% of 2024 payments
All-time payments by company (2018-2024) ›
Seattle Genetics, Inc.
$11,221
AstraZeneca Pharmaceuticals LP
$3,567
G1 Therapeutics, Inc.
$1,500
Blueprint Medicines Corporation
$1,498
Rigel Pharmaceuticals, Inc.
$1,019
Novartis Pharmaceuticals Corporation
$525
E.R. Squibb & Sons, L.L.C.
$515
Janssen Biotech, Inc.
$507
PFIZER INC.
$369
Incyte Corporation
$283
Takeda Pharmaceuticals U.S.A., Inc.
$247
Genentech USA, Inc.
$216
Amgen Inc.
$199
Pharmacyclics LLC, An AbbVie Company
$198
Alexion Pharmaceuticals, Inc.
$190
Eisai Inc.
$188
Servier Pharmaceuticals LLC
$159
EMD Serono, Inc.
$143
Lilly USA, LLC
$135
Daiichi Sankyo Inc.
$132
Bayer HealthCare Pharmaceuticals Inc.
$131
TESARO, Inc.
$121
ABBVIE INC.
$120
Celgene Corporation
$111
Gilead Sciences, Inc.
$111
GENZYME CORPORATION
$102
EISAI INC.
$86
Acrotech Biopharma Inc.
$84
ARRAY BIOPHARMA INC
$75
Clovis Oncology, Inc.
$63
Merck Sharp & Dohme LLC
$62
SOBI, INC
$62
AMAG Pharmaceuticals, Inc.
$49
MEDIVATION FIELD SOLUTIONS LLC
$49
Tempus AI, Inc
$44
Mirati Therapeutics, Inc.
$44
Seagen Inc.
$40
Spectrum Pharmaceuticals Inc.
$38
Lexicon Pharmaceuticals, Inc.
$35
Kite Pharma, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$31
Merck Sharp & Dohme Corporation
$30
Karyopharm Therapeutics Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
AbbVie, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$25
INSYS Therapeutics Inc
$24
Stemline Therapeutics Inc.
$23
Genmab U.S., Inc.
$23
Otsuka America Pharmaceutical, Inc.
$22
BeiGene USA, Inc.
$21
Dova Pharmaceuticals
$21
Myriad Genetic Laboratories, Inc.
$21
SpringWorks Therapeutics, Inc.
$20
GlaxoSmithKline, LLC.
$20
Verastem, Inc.
$18
Astellas Pharma US Inc
$17
JAZZ PHARMACEUTICALS INC.
$17
Pharmacosmos Therapeutics Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Foundation Medicine, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$12
Advanced Accelerator Applications
$12
Agios Pharmaceuticals, Inc.
$12
Prometheus Laboratories Inc.
$11
Top 3 companies account for 65.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avastin · BALVERSA · BELEODAQ · BENDEKA · BRUKINSA · Balversa · Bavencio · CABLIVI · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONOFERRIC · MYLOTARG · MYRISK · NINLARO · Neulasta · Nplate · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Perjeta · Pomalyst · Proleukin · Prolia · REBLOZYL · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNAGIS · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tavalisse · Tivdak · ULTOMIRIS · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA · Zevalin
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
4,140
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
RIDDLE MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jacobs is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jacobs experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Jacobs performed 18,800 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jacobs receive payments from pharmaceutical companies?
Yes. Dr. Jacobs received a total of $24,784 from 65 companies across 365 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobs's costs compare to other internal medicine physicians in Media?
Dr. Jacobs's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Media
Browse internal medicine physicians in Media ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
G1 Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from G1 Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology